Company filings profile · CIK 0001176309
ORAMED PHARMACEUTICALS INC. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for ORAMED PHARMACEUTICALS INC. (ORMP): 13 filings in the last 90 days vs 10 in the prior 90 (filing-velocity rising ↑ · 1.3×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.
Material 8-K events — ORAMED PHARMACEUTICALS INC.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 17, 2026 | Item 5.07 | ↗ |
| Jun 30, 2026 | Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition | ↗ |
| Feb 20, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jan 14, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
Watch ORAMED PHARMACEUTICALS INC. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 17, 2026 | 8-K | Item 5.07 | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 10, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| Aug 3, 2026 | ARS | ARS | ↗ |
| Aug 3, 2026 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ↗ |
| Aug 3, 2026 | DEF 14A | PROXY STATEMENT | ↗ |
| Jul 22, 2026 | SCHEDULE 13D/A | ↗ | |
| Jul 2, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jul 2, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Jul 1, 2026 | 144 | ↗ | |
| Jul 1, 2026 | 144 | ↗ | |
| Jun 30, 2026 | 8-K | Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 29, 2026 | SCHEDULE 13G/A | ↗ | |
| Jun 17, 2026 | SCHEDULE 13D/A | ↗ | |
| May 19, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| May 15, 2026 | NT 10-Q | NOTIFICATION OF LATE FILING | ↗ |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 14, 2026 | 3 | ↗ | |
| May 14, 2026 | SCHEDULE 13D | ↗ | |
| Mar 31, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition | ↗ |
| Mar 31, 2026 | 4 | ↗ | |
| Mar 31, 2026 | 4 | ↗ | |
| Mar 26, 2026 | 10-K | ANNUAL REPORT | ↗ |
| Mar 18, 2026 | 4 | ↗ | |
| Mar 18, 2026 | 4 | ↗ | |
| Mar 18, 2026 | 4 | ↗ | |
| Mar 18, 2026 | 4 | ↗ | |
| Mar 16, 2026 | 4 | ↗ | |
| Feb 20, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Feb 19, 2026 | SCHEDULE 13D/A | ↗ | |
| Feb 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 9, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 29, 2026 | SCHEDULE 13D | ↗ | |
| Jan 29, 2026 | 4 | ↗ | |
| Jan 29, 2026 | 4 | ↗ | |
| Jan 29, 2026 | 4 | ↗ | |
| Jan 29, 2026 | 4 | ↗ | |
| Jan 21, 2026 | 4 | ↗ | |
| Jan 14, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |